Gentas Biotechnology
Monday, February 26, 2024
Royale
Contract Research Organization
Gentas' mission is to bridge BioPharma’s translational gap by providing preclinical testing services using miniature swine models. Gentas will dramatically improve the success rate for testing by 1) improving the predictability of testing from rodents in earlier stages and 2) lowering the total cost of R&D. In short, Gentas will enable customers to leverage the predictive miniature swine platform to deliver large animal model insight at a fraction of the cost and twice the speed.
State
Shanghai
Country
China
Website
https://www.linkedin.com/pulse/%25E9%2587%2591%25E8%25B7%2583%25E7%2594%259F%25E7%2589%25A9%25E5%2585%25A5%25E9%25A9%25BBjlabsshanghai%25E5%2595%25A6-gentasbiotech/?trackingId=cF3vLJCyRL%2Br58X86LDsYA%3D%3D
CEO/Top Company Official
Dr. Zhi Chen
Lead Product in Development
Preclinical R&D testing platforms leveraging miniature swine models
Development Phase of Primary Product
Pre-Clinical
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}